PROVIDER PROFILE · NPI 1235802067
Alvin Choy
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
79
Beneficiaries
—
Total drug cost
$421K
Distinct drugs
2
Brand share
100.0%
Top prescribed drugs
Cabotegravir/Rilpivirine50 claims
Cabotegravir29 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE